Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2021

Molecular-driven therapy in ovarian cancer

Combinations with immune therapy in ovarian cancer

Date

16 Sep 2021

Session

Molecular-driven therapy in ovarian cancer

Topics

Tumour Site

Ovarian Cancer

Presenters

Florence Joly Lobbedez

Authors

F. Joly Lobbedez

Author affiliations

  • Centre Francois Baclesse, 14076 - Caen/FR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: Clare Scott

Session: Molecular-driven therapy in ovarian cancer

Resources:

Slides

New targets in ovarian cancer

Presenter: David SP Tan

Session: Molecular-driven therapy in ovarian cancer

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.